HIINX
Price
$61.72
Change
-$0.22 (-0.36%)
Updated
Aug 28 closing price
Net Assets
4.01B
VTISX
Price
$197.88
Change
-$1.05 (-0.53%)
Updated
Aug 28 closing price
Net Assets
645.82B
Interact to see
Advertisement

HIINX vs VTISX

HIINX vs VTISX Comparison Chart in %
View a ticker or compare two or three
VS
HIINX vs. VTISX commentary
Aug 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIINX is a Buy and VTISX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 646B vs. HIINX (4.01B). HIINX pays higher dividends than VTISX: HIINX (2.95) vs VTISX (2.59). HIINX was incepted earlier than VTISX: HIINX (24 years) vs VTISX (10 years). HIINX (1.23) is less costly to investors than VTISX (0.05). HIINX is a more actively managed with annual turnover of: 17.00 vs. VTISX (4.00). HIINX has a lower initial minimum investment than VTISX: HIINX (2500) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 23.12 vs. HIINX (18.05). HIINX return over 5 years is better than : 42.18 vs. VTISX (39.55).
HIINXVTISXHIINX / VTISX
Total Expense Ratio1.140.052,478%
Annual Report Gross Expense Ratio1.230.052,674%
Fund Existence24 years10 years-
Gain YTD13.49816.14284%
Front LoadN/AN/A-
Min. Initial Investment250030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.01B646B1%
Annual Yield % from dividends2.952.59114%
Returns for 1 year18.0523.1278%
Returns for 3 years58.6960.6397%
Returns for 5 years42.1839.55107%
Returns for 10 years17.35102.4317%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWCX106.39-0.30
-0.28%
American Funds New World R-3
UMBMX27.74-0.26
-0.93%
Carillon Scout Mid Cap I
TRZIX20.82-0.30
-1.42%
T. Rowe Price Small-Cap Index Z
ROFCX14.95-0.22
-1.45%
Royce Small-Cap Opportunity Consult
RYCFX54.27-1.54
-2.76%
Rydex Biotechnology C